UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 30, 2004
Commission File No. 0-11178
-------
UTAH MEDICAL PRODUCTS, INC.
---------------------------
(Exact name of Registrant as specified in its charter)
UTAH 87-0342734
------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
7043 South 300 West
Midvale, Utah 84047
--------------------
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
--------------
--------------------------------------------------------------------------------
ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
--------------------------------------------------------------------------------
Effective August 30, 2004, Utah Medical Products, Inc. modified its unsecured
line-of-credit with U.S. Bank to extend the maturity date of the note by one
year to May 31, 2006, and to decrease the amount of the note to $5,000,000. All
other terms of the note remain the same.
--------------------------------------------------------------------------------
SIGNATURES
--------------------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UTAH MEDICAL PRODUCTS, INC.
---------------------------
REGISTRANT
Date: 9/1/04 By: /s/ Kevin L. Cornwell
-------------------- ------------------------
Kevin L. Cornwell
CEO